Additionally, immunohistochemistry revealed decreased expression of Ki-67 and S100A11 in the tumors (Fig. 7D), confirming the potential of hsa_circ_0000105 as a therapeutic target in NPC. Here, MKI67 is linked to nasopharyngeal carcinoma.